IRIS
Lorusso, Domenica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.428
NA - Nord America 643
EU - Europa 213
SA - Sud America 213
AF - Africa 14
OC - Oceania 3
Totale 2.514
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 990
US - Stati Uniti d'America 615
CN - Cina 342
BR - Brasile 188
DE - Germania 48
IT - Italia 46
HK - Hong Kong 28
FI - Finlandia 19
GB - Regno Unito 17
MX - Messico 16
CZ - Repubblica Ceca 14
CA - Canada 11
IE - Irlanda 9
IN - India 9
NL - Olanda 8
BD - Bangladesh 7
EC - Ecuador 7
FR - Francia 7
ZA - Sudafrica 7
AR - Argentina 6
SE - Svezia 6
AT - Austria 5
ES - Italia 5
IQ - Iraq 5
LT - Lituania 5
PE - Perù 5
TR - Turchia 5
BE - Belgio 4
GR - Grecia 4
JP - Giappone 4
RU - Federazione Russa 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
JO - Giordania 3
LK - Sri Lanka 3
TH - Thailandia 3
UA - Ucraina 3
UY - Uruguay 3
BO - Bolivia 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
PL - Polonia 2
TW - Taiwan 2
VE - Venezuela 2
VN - Vietnam 2
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
IL - Israele 1
KH - Cambogia 1
KR - Corea 1
KW - Kuwait 1
MA - Marocco 1
MD - Moldavia 1
MM - Myanmar 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
TN - Tunisia 1
Totale 2.514
Salva come PNG Salva come JPEG
Città #
Singapore 428
Shanghai 331
Santa Clara 51
Boardman 32
Seattle 30
Chandler 29
Ashburn 27
Hong Kong 24
São Paulo 22
Helsinki 19
Los Angeles 13
Wilmington 13
Munich 10
Reston 10
Dublin 9
Mexico City 9
Milan 9
New York 9
Brno 8
London 7
Lawrence 6
Olomouc 6
Princeton 6
Belo Horizonte 5
Johannesburg 5
Porto Alegre 5
San Mateo 5
Toronto 5
Athens 4
Brussels 4
Florianópolis 4
Guayaquil 4
Hangzhou 4
Nuremberg 4
Paris 4
Rio de Janeiro 4
Tokyo 4
Turin 4
Amman 3
Baghdad 3
Bangkok 3
Buffalo 3
Campinas 3
Colombo 3
Iztapalapa 3
Jundiaí 3
Montevideo 3
Snodland 3
Sorocaba 3
Tashkent 3
Ahmedabad 2
Ann Arbor 2
Atlanta 2
Auckland 2
Bariri 2
Barueri 2
Benin City 2
Bishkek 2
Bologna 2
Brasília 2
Campos dos Goytacazes 2
Caxias do Sul 2
Cipolletti 2
Corbetta 2
Council Bluffs 2
Delhi 2
Dubai 2
Edgerton 2
Fairfield 2
Frankfurt am Main 2
Gonars 2
Iguape 2
João Monlevade 2
Leawood 2
Lima 2
Markham 2
Modena 2
Naples 2
Ottawa 2
Pamplona 2
Pavia 2
Phoenix 2
Pinhais 2
Pune 2
Recife 2
Ribeirão Preto 2
Rome 2
Santa Maria 2
Santo André 2
Santos 2
São Bernardo do Campo 2
Volta Redonda 2
Agadir 1
Ajman 1
Alegrete 1
Almaty 1
Almeirim Municipality 1
Almirante Brown 1
Almirante Tamandaré 1
Amsterdam 1
Totale 1.301
Salva come PNG Salva come JPEG
Nome #
A phase II randomised (calibrated design) study on the activity of the single-agent trabectedin in metastatic or locally relapsed uterine leiomyosarcoma 65
Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer 44
Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoprotein 38
Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia) 32
Trabectedin as a chemotherapy option for patients with BRCA deficiency 30
Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience 27
Phase I Study of Rucaparib in Combination with Bevacizumab in Ovarian Cancer Patients: Maximum Tolerated Dose and Pharmacokinetic Profile 27
Accuracy of pre-operative hysteroscopic guided biopsy for predicting final pathology in uterine malignancies 27
A Treatment Selection Protocol for Recurrent Ovarian Cancer Patients: The Role of FDG-PET/CT and Staging Laparoscopy 26
Sentinel Node Mapping in Endometrial Cancer By Using Hysteroscopic Injection of Indocyanine Green and Laparoscopic Near-Infrared Fluorescence Imaging: A Preliminary Experience 22
Regarding "The Role of Routine Peritoneal and Omental Biopsies at Risk-reducing Salpingo-oophorectomy" 21
Implementation of Extensive Cytoreduction Resulted in Improved Survival Outcomes for Patients with Newly Diagnosed Advanced-Stage Ovarian, Tubal, and Peritoneal Cancers 20
Do you agree with populations that have been defined as 'noncandidates' to receiving platinum? 19
Celecoxib plus cartioplatin in heavily pre-treated patients with recurrent ovarian carcinoma: Preliminary results of a Phase II study 19
Phase I study of gemcitabine and liposomal doxorubicin in relapsed ovarian cancer 19
Minimally Invasive Surgical Staging for Ovarian Carcinoma: A Propensity-Matched Comparison With Traditional Open Surgery 18
When Does Neoadjuvant Chemotherapy Really Avoid Radiotherapy? Clinical Predictors of Adjuvant Radiotherapy in Cervical Cancer 17
Lurbinectedin versus pegylated liposomal doxorubicin or topotecan in patients with platinum-resistant ovarian cancer: A multicenter, randomized, controlled, open-label phase 3 study (CORAIL) 17
Clinical research disruption in the post-COVID-19 era: will the pandemic lead to change? 16
Advanced vulvar carcinoma: Is it worth operating? A perioperative management protocol for radical and reconstructive surgery 16
Knowledge and attitudes towards clinical trials among women with ovarian cancer: results of the ACTO study 16
[Clinical applications of bevacizumab in the treatment of colorectal and ovarian cancer.] 14
Nomogram-based prediction of cervical dysplasia persistence/recurrence 14
Advanced ovarian cancer: Omental bursa, lesser omentum, celiac, portal and triad nodes spread as cause of inaccurate evaluation of residual tumor 14
Efficacy of adjuvant chemotherapy in early stage uterine leiomyosarcoma: A systematic review and meta-analysis 13
Reply to P.-H. Luo et al 13
Surgical Techniques for Diaphragmatic Resection During Cytoreduction in Advanced or Recurrent Ovarian Carcinoma A Systematic Review and Meta-analysis 13
Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) - Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS) 13
Phase II study of oxaliplatin (OXA) and docetaxel (DTX) in recurrent platinum-sensitive ovarian cancer 13
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms 13
Assessing the Risk of Occult Cancer and 30-day Morbidity in Women Undergoing Risk-reducing Surgery: A Prospective Experience. 13
Incorporation of anti-PD1 or anti PD-L1 agents to platinum-based chemotherapy for the primary treatment of advanced or recurrent endometrial cancer. A meta-analysis 12
A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses 12
Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial 12
Peritoneal cytology as prognostic factor in cervical cancer 12
"Tumori della vulva e della vagina" 12
3D vision improves outcomes in early cervical cancer treated with laparoscopic type B radical hysterectomy and pelvic lymphadenectomy 12
Bulky mesonephric adenocarcinoma of the uterine cervix treated with neoadjuvant chemotherapy and radical surgery: report of the first case 12
Randomized phase III trial on niraparib-TSR-042 (dostarlimab) versus physician's choice chemotherapy in recurrent ovarian, fallopian tube, or primary peritoneal cancer patients not candidate for platinum retreatment: NItCHE trial (MITO 33) 12
TP53 mutations and survival in ovarian carcinoma patients receiving first-line chemotherapy plus bevacizumab: Results of the MITO16A/MaNGO OV-2 study 12
A laparoscopy-based score to predict surgical outcome in patients with advanced ovarian carcinoma: A pilot study 12
ONCOMOVIES: CANCER IN CINEMA 12
Use of Adjuvant Therapy in Patients with FIGO Stage III Endometrial Carcinoma: A Multicenter Retrospective Study 11
Management of Adverse Events During Rucaparib Treatment for Relapsed Ovarian Cancer: A Review of Published Studies and Practical Guidance 11
Management of stage III and IVa uterine cancer 11
A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer - A Multicentre Italian Trial in Ovarian cancer (MITO-5) study 11
Advances in laparoscopic surgery for cervical cancer 11
New prophylactics human papilloma virus (HPV) vaccines against cervical cancer 11
PARPi related toxicities: do we need more appropriate instruments to evaluate it? 11
A phase I-II study of elacytarabine (CP-4055) in the treatment of patients with ovarian cancer resistant or refractory to platinum therapy 11
Assessing the risk of pelvic and para-aortic nodal involvement in apparent early-stage ovarian cancer: A predictors- and nomogram-based analyses 11
Gemcitabine (GEM) and liposomal doxorubicin (PLO) in recurrent/metastatic breast carcinoma: A phase II study 10
Artificial intelligence estimates the impact of human papillomavirus types in influencing the risk of cervical dysplasia recurrence: progress toward a more personalized approach 10
Carboplatin-Paclitaxel Versus Cisplatin-Ifosfamide in the Treatment of Uterine Carcinosarcoma A Retrospective Cohort Study 10
Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: Association with pathological response to treatment and clinical outcome 10
Clear cell carcinoma of the endometrium 10
Multicentre Italian Trials in Ovarian cancer (MITO) translational group. Development and validation of a microRNA-based signature (MiROvaR) to predict early relapse or progression of epithelial ovarian cancer: a cohort study 10
Adjuvant Treatment Recommendations in Early-Stage Endometrial Cancer: What Changes With the Introduction of The Integrated Molecular-Based Risk Assessment 10
Prevention of chemotherapy-induced nausea and vomiting and the role of neurokinin 1 inhibitors: from guidelines to clinical practice in solid tumors 10
Impact of Recurrence of Ovarian Cancer on Quality of Life and Outlook for the Future 10
Refining Adjuvant Therapy for Endometrial Cancer: New Standards and Perspectives 10
Prospective Validation Study of a Predictive Score for Operability of Recurrent Ovarian Cancer The Multicenter Intergroup Study DESKTOP II. A Project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO 10
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial 10
A critical assessment on the role of sentinel node mapping in endometrial cancer 10
TERAPIA PRIMARIA DEL CARCINOMA DELL'ENDOMETRIO: CHEMIOTERAPIA 10
Phase II study of oxaliplatin (OXA) and docetaxel (DTX) in recurrent ovarian cancer 10
Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial 9
Rucaparib: a new treatment option for ovarian cancer 9
Fertility sparing surgery in early stage epithelial ovarian cancer 9
Quality of life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer 9
Preexisting TP53-Variant Clonal Hematopoiesis and Risk of Secondary Myeloid Neoplasms in Patients With High-grade Ovarian Cancer Treated With Rucaparib 9
Treatment modalities for recurrent high-grade vaginal intraepithelial neoplasia 9
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients 9
Bevacizumab as maintenance treatment in BRCA mutated patients with advanced ovarian cancer: A large, retrospective, multicenter case-control study 9
Tumori dell'ovaio 9
Surgical Management and Prognostic Factors of Vulvovaginal Melanoma 9
Short-course olanzapine to prevent delayed emesis following carboplatin/paclitaxel for gynecologic cancer: a randomised study 9
Pharmacotherapy of cervical cancer 9
Morcellation of undiagnosed uterine sarcoma: A critical review 9
Management of ovarian cancer: guidelines of the Italian Medical Oncology Association (AIOM) 9
High-Risk Borderline Ovarian Tumors: Analysis of Clinicopathological Features and Prognostic Impact of Different Follow-Up Strategies 9
Carboplatin and Pegylated Liposomal Doxorubicin for Advanced Ovarian Cancer: Preliminary Activity Results of the MITO-2 Phase III Trial 9
Adoptive immunotherapy with cytokine-induced killer cells generated with a new GMP-grade protocol 9
A fully virtual and nationwide molecular tumor board for gynecologic cancer patients: the virtual experience of the MITO cooperative group 8
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study 8
Gynecologic Cancer Intergroup (GCIG) Consensus Review for Ovarian Germ Cell Tumors 8
Tailoring adjuvant treatment in patients with uterine cancer 8
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 study 8
Phase II Trial on Cisplatin-Adriamycin-Paclitaxel Combination as Neoadjuvant Chemotherapy for Locally Advanced Cervical Adenocarcinoma 8
CASE CONTROL STUDY ON TWO DIFFERENT CHEMOTHERAPY REGIMENS IN ADVANCED MIXED MULLERIAN TUMOURS 8
Long-term safety of fertility sparing surgery in early stage ovarian cancer: Comparison to standard radical surgical procedures 8
Preclinical and Clinical Evidence of Lurbinectedin in Ovarian Cancer: Current Status and Future Perspectives 8
Antitumor activity of the poly(ADP-ribose) polymerase inhibitor rucaparib as monotherapy in patients with platinum-sensitive, relapsed, BRCA-mutated, high-grade ovarian cancer, and an update on safety 8
Investigating the role of immunotherapy in advanced/recurrent female genital tract melanoma: a preliminary experience 8
Il carcinoma dell'ovaio 8
Role of pegylated liposomal doxorubicin (PLD) in epithelial ovarian cancer 8
Tumori dell'apparato genitale femminile 8
The role of immunotherapy in advanced and recurrent MMR deficient and proficient endometrial carcinoma 8
Lenvatinib plus Pembrolizumab for Advanced Endometrial Cancer 8
Efficacy and Safety of First-line Single-Agent Carboplatin vs Carboplatin Plus Paclitaxel for Vulnerable Older Adult Women With Ovarian Cancer: A GINECO/GCIG Randomized Clinical Trial 8
Totale 1.339
Salva come PNG Salva come JPEG
Categoria #
all - tutte 33.667
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.667
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202126 0 0 0 0 0 7 4 3 6 3 0 3
2021/202219 2 0 0 2 0 0 0 2 1 2 4 6
2022/202387 13 2 7 13 2 8 0 11 16 9 5 1
2023/2024907 6 5 11 3 0 8 2 0 271 21 187 393
2024/20251.864 82 108 147 44 17 297 336 248 585 0 0 0
Totale 2.903